Press release
Idiopathic Pulmonary Fibrosis Market Size Set to Hit USD 6.16 billion by 2030 with a CAGR of 7.0%: AMR
Idiopathic Pulmonary Fibrosis Market
The Global Idiopathic Pulmonary Fibrosis Market Size was Valued at USD 3.12 billion in 2020 and is poised to Reach USD 6.16 billion by 2030, witnessing a Growing CAGR of 7.0% from 2021 to 2030.
Covid-19 Scenario
โข There has been decline in the number of idiopathic pulmonary fibrosis patient visits in hospitals & clinics for idiopathic pulmonary fibrosis therapy (IPF) to avoid cross-contamination. Moreover, there has been apostponement of elective surgeries to take care of Covid-infected patients.
โข The idiopathic pulmonary fibrosis market was impacted negatively by the outbreak of the Covid-19 pandemic. The demand for drugs reduced from retail pharmacies and online providers due to reduced therapy sessions and treatments.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4407
๐๐ง๐๐ซ๐๐๐ฌ๐ ๐ข๐ง ๐ข๐ง๐๐ข๐๐๐ง๐๐๐ฌ ๐จ๐ ๐๐๐ง๐๐๐ซ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐, ๐๐๐ฏ๐จ๐ซ๐๐๐ฅ๐ ๐ซ๐๐ข๐ฆ๐๐ฎ๐ซ๐ฌ๐๐ฆ๐๐ง๐ญ ๐ฉ๐จ๐ฅ๐ข๐๐ข๐๐ฌ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐ ๐๐ฒ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐๐ซ๐ฌ & ๐ข๐ง๐ฌ๐ฎ๐ซ๐๐ง๐๐ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐ซ๐ฌ, ๐๐ง๐ ๐ซ๐ข๐ฌ๐ ๐ข๐ง ๐๐ข๐ ๐๐ซ๐๐ญ๐ญ๐ ๐ฌ๐ฆ๐จ๐ค๐ข๐ง๐ ๐๐ซ๐ข๐ฏ๐ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ข๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐ฉ๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ. ๐๐จ๐ฐ๐๐ฏ๐๐ซ, ๐ญ๐ก๐ ๐ฎ๐ง๐๐ฏ๐๐ข๐ฅ๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐ฉ๐ซ๐จ๐ฉ๐๐ซ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐จ๐ฉ๐ญ๐ข๐จ๐ง๐ฌ ๐ซ๐๐ฌ๐ญ๐ซ๐๐ข๐ง๐ฌ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก. ๐๐ง ๐ญ๐ก๐ ๐จ๐ญ๐ก๐๐ซ ๐ก๐๐ง๐, ๐ซ๐ข๐ฌ๐ ๐ข๐ง ๐ง๐ฎ๐ฆ๐๐๐ซ ๐จ๐ ๐ฉ๐ข๐ฉ๐๐ฅ๐ข๐ง๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐ง๐ ๐ฎ๐ง๐ญ๐๐ฉ๐ฉ๐๐ ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ข๐ง ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ข๐๐ฌ ๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ ๐ง๐๐ฐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ฆ๐ข๐ง๐ ๐ฒ๐๐๐ซ๐ฌ.
๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:-
โข AstraZeneca Plc,
โข Biogen Inc.,
โข Boehringer Ingelheim,
โข F. Hoffmann-La Roche,
โข FibroGen, Inc.,
โข Mission Therapeutics.,
โข GNI Group Ltd,
โข Galapagos NV,
โข Biogen,
โข Bristol-Myers Squibb Company.,
โข Shiongi Co Ltd.
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
Based on drug type, the pirfenidone segment accounted for the highest share in 2020, holding around three-fourths of the global idiopathic pulmonary fibrosis market, and is expected to continue its leadership status during the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 7.2% from 2021 to 2030. This is due to rise in adoption of pirfenidone drugs such as Esbriet and Pirespa across the world. The research also analyzes the nintedanib segment.
Based on distribution channel, the retail pharmacies segment accounted for the highest share in 2020, contributing to nearly half of the global idiopathic pulmonary fibrosis market, and is estimated to continue its lead position during the forecast period. This is attributed to rapid increase in rate of idiopathic pulmonary fibrosis among the geriatric population, technological advancements, and lifestyle changes worldwide. However, the online providers segment is expected to portray the largest CAGR of 8.5% from 2021 to 2030. This is due to offers and discounts offered by providers and the availability of different types of drugs under a single platform.
Based on region, North America contributed to the highest market share in 2020, holding more than two-fifths of the global idiopathic pulmonary fibrosis market, and is projected to continue its lead in terms of revenue by 2030. This is attributed to high expenditure on R&D activities, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 8.9% during the forecast period, owing to improvement in R&D facilities and rapidly developing economic conditions.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4407
Key Benefits For Stakeholders
โข An in-depth idiopathic pulmonary fibrosis market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
โข A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
โข The projections in this report are made by analyzing the current trends and future idiopathic pulmonary fibrosis market potential from 2021 to 2030, in terms of value.
โข An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
โข Key market players within the idiopathic pulmonary fibrosis market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the idiopathic pulmonary fibrosis market.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Pulmonary Fibrosis Market Size Set to Hit USD 6.16 billion by 2030 with a CAGR of 7.0%: AMR here
News-ID: 3373941 • Views: โฆ
More Releases from Allied Market Research (AMR)
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521
Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849
Market Drivers and Challenges:
- The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654
What is Sunflower Lecithin?
Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156
Market Drivers, Restraints, and Opportunities
Drivers:
- Technological advancements and innovations inโฆ
More Releases for Idiopathic
Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89โฆ
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
โฆ
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,โฆ
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth โฆ
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. Inโฆ
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, โฆ
Global Idiopathic Scoliosis Treatmentโโโโโโโ Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatmentโโโโโโโ Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sampleโฆ
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipationโฆ
